D‑Rubicin 50 mg (Doxorubicin) Injection – Chemotherapy Medicine in Pakistan D‑Rubicin 50 mg Injection contains doxorubicin, a widely used anthracycline chemotherapy agent essential in treating a broad spectrum of cancers, including breast, ovarian, bladder, lung cancers, Hodgkin’s and non‑Hodgkin’s lymphomas, and certain leukemias. This injectable medicine works by intercalating DNA and inhibiting cancer cell division, making it a cornerstone in many combination chemotherapy protocols.Due to its cytotoxic action and potential side effects — including bone marrow suppression, cardiac toxicity, hair loss, and nausea — this medicine is prescription‑only and must be administered by qualified oncology specialists in a clinical setting with regular monitoring.